Table 3.
Comparison of echocardiographic abnormalities among cases and controls.
| Echocardiographic abnormality | Cases (n = 200) | Controls (n = 50) | P value |
|---|---|---|---|
| LV diastolic dysfunction | 78 (39%) | 4 (8%) | <0.0001 |
| Valvular regurgitation (MR, AR, PR, TR) | 61 (30.5%) | 5 (10%) | 0.002 |
| Reduced FS(<30%) | 64 (32%) | 2 (4%) | <0.0001 |
| Reduced LVEF | 32 (16%) | 2 (4%) | 0.035 |
| Dilated cardiomyopathy | 24 (12%) | 1 (2%) | 0.035 |
| Pulmonary hypertension | 30 (15%) | 3 (6%) | 0.106 |
| Regional wall motion abnormality | 2 (1%) | 0 (0%) | 1.0 |
| Pericardial effusion | 14 (7%) | 0 (0%) | 0.079 |
MR, mitral regurgitation; AR, aortic regurgitation; PR, pulmonary regurgitation; TR, tricuspid regurgitation; FS, fractional shortening; LVEF, left ventricular ejection fraction.